SLGL
$72.97-8.74 (-10.70%)
Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, and internationally.
Recent News
Sol-Gel Technologies Ltd. (SLGL) Reports Q4 Loss, Misses Revenue Estimates
SolGel Technologies (SLGL) delivered earnings and revenue surprises of -374.36% and -89.29%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Sol-Gel Technologies (NASDAQ:SLGL) shareholders have earned a 940% return over the last year
Active investing isn't easy, but for those that do it, the aim is to find the best companies to buy, and to profit...
We Think Sol-Gel Technologies (NASDAQ:SLGL) Can Easily Afford To Drive Business Growth
Just because a business does not make any money, does not mean that the stock will go down. For example, Sol-Gel...
Insiders At Sol-Gel Technologies See Good Returns After Buying Stock Worth US$867.1k
Insiders who bought Sol-Gel Technologies Ltd. ( NASDAQ:SLGL ) stock lover the last 12 months are probably not as...
Sol-Gel Technologies (NASDAQ:SLGL) shareholders have earned a 240% return over the last year
Unfortunately, investing is risky - companies can and do go bankrupt. On the other hand, if you find a high quality...